Plasma concentrations of VEGF and bFGF in patients with gastric carcinoma

Cancer Letters

Volumn 153, Issue 1-2, 2000, Pages 7-12

  Yoshikawa, Takaki ^a   Tsuburaya, Akira ^a   Kobayashi, Osamu ^a   Sairenji, Motonori ^a   Motohashi, Hisahiko ^a   Yanoma, Shunsuke ^b   Noguchi, Yoshikazu ^c  

^a KANAGAWA CANCER CENTER   (Japan)

^b Research Institute   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Basic fibroblast growth factor; Gastric cancer; Prognostic factor; Vascular endothelial growth factor

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; VASCULOTROPIN;

ADULT; ARTICLE; BLOOD LEVEL; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; SOLID TUMOR; STOMACH CANCER;

ENDOTHELIAL GROWTH FACTORS; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; LYMPHOKINES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034729146     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00426-7     Document Type: Article

References (27)

1. Parkin D.M., Laara E., Muir C.S. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int. J. Cancer. 41:1988;184-197.
2. Koga S., Kishimoto H., Tanaka K., Kawaguchi H. Clinical and pathologic evaluation of patients with recurrence of gastric cancer more than five years postoperatively. Am. J. Surg. 136:1978;317-321.
3. Folkman J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285:1971;1182-1186.
4. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1:1995;27-31.
5. Folkman J., Klagsbrun M. Angiogenic factors. Science. 235:1987;442-447.
6. Leung D.W., Cachianes G., Kuang W.J., Goeddel D.V., Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 246:1989;1306.
7. Ferrara N., Houck K., Jakeman L., Leung D.W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr. Rev. 13:1992;18-32.
8. New B., Yeoman L. Identification of basic fibroblast growth factor sensitivity and receptor and ligand expression in human colon tumor cell lines. Cell. Physiol. 150:1992;320-326.
9. Ferrara N., Houck K., Jakeman L.B., Winer J., Leung D.W. The vascular endothelial growth factor family of polypeptides. J. Cell. Biochem. 47:1991;211-218.
10. Maeda K., Chung Y., Ogawa Y., Takatsuka S., Kang S., Ogawa M., Sawada T., Sowa M. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer. 77:1996;858-863.
11. Tanigawa N., Amaya H., Matsumura M., Shimomatsuya T. Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma. J. Clin. Oncol. 15:1997;826-832.
12. Takahashi Y., Cleary K.R., Mai M., Kitadai Y., Bucana C.D., Ellis L.M. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. Clin. Cancer Res. 2:1996;1679-1684.
13. Salven P., Maenpaa H., Orpana A., Alitalo K., Joensuu H. Serum vascular endothelial growth factor is often elevated in disseminated cancer. Clin. Cancer Res. 3:1997;647-651.
14. Gonzalez A.M., Buscaglia M., Ong M., Baird A. Distribution of basic fibroblast growth factor in the 18-day rat fetus: localization in the basement membranes of diverse tissues. J. Cell. Biol. 110:1990;753-765.
15. Abe T., Okamura K., Ono M., Kohno K., Mori T., Hori S., Kuwano M. Induction of vascular endothelial tubular morphogenesis by human glioma cells: a model system for tumor angiogenesis. J. Clin. Invest. 92:1993;54-61.
16. Nanus D.M., Schmitz-Drager B.J., Motzer R.J., Lee A.C., Vlamis V., Cordon-Cargo C., Ablino A.P., Reuter V.E. Expression of basic fibroblast growth factor in primary human renal tumors: correlation with poor survival. J. Natl. Cancer Inst. 85:1993;1597-1599.
17. Nguyen M., Watanabe H., Budson A.E., Richie J.P., Hayes D.F., Folkman J. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J. Natl. Cancer Inst. 86:1994;356-361.
18. Japanese Gastric Cancer Association, Japanese classification of gastric carcinoma, 2nd English edition, Gastric Cancer1 (1998) 10-24.
19. Folkman J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst. 82:1990;4-6.
20. Gabriovich D.I., Chen H.L., Girgis K.R., Cunnigham H.T., Meny G.M., Nadaf S., Kavanaugh D., Carbone D.P. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat. Med. 2:1996;1096-1103.
21. Hermanek P., Wittekind C. News of TNM and its use for classification of gastric cancer. World J. Surg. 19:1995;491-495.
22. Tahara E. Molecular biology of gastric cancer. World J. Surg. 19:1995;484-490.
23. Ismail T., Hallissey M.T., Fielding J.W. Pathologic factors for gastrointestinal cancer. World J. Surg. 19:1995;178-183.
24. Kirkwood K.S., Khitin L.M., Barwick K.W. Prognostic indicators for gastric cancer. Surg. Oncol. Clin. N. Am. 6:1997;495-514.
25. Kitamura M., Toi M., Arai K., Iwasaki Y., Suzuki H., Matsuo K. Concentrations of vascular endothelial growth factor in the sera of gastric cancer patients. Oncol. Rep. 5:1998;1419-1424.
26. Hyodo I., Doi T., Endo H., Hosokawa Y., Nishikawa Y., Tanimizu M., Jinno K., Kotani Y. Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer. Eur. J. Cancer. 34:1998;2041-2045.
27. Mohle R., Green D., Moore M.A.S., Nachman R.L., Rafii S. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and plateles. Proc. Natl. Acad. Sci. USA. 94:1997;663-668.